News
Zacks Investment Research on MSN4h
Exelixis Gains 15.6% YTD: How Should You Play the Stock?
Exelixis’ EXEL year-to-date performance has been good. Shares of the biotech company have gained 15.6% compared with the ...
Today’s Stock of the Day list features three high-potential picks: Shilpa Medicare, Pfizer, and Vishal Mega Mart. Shilpa ...
Pfizer (PFE) recently announced positive topline results from the Phase 3 EV-303 clinical trial, showcasing promising outcomes for PADCEV in treating muscle-invasive bladder cancer. Over the last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results